EchoSolv AS vs Study Watch with Irregular Pulse Monitor (Home)
AI Verdict
Choose EchoSolv AS if…
Choose EchoSolv AS if your cardiology department needs to efficiently and accurately identify patients at high risk for severe aortic stenosis from existing echocardiogram measurements. This tool is ideal for streamlining clinical workflows by providing rapid, AI-powered decision support and helping prioritize studies for closer review without requiring EMR integration.
View EchoSolv AS →Choose Study Watch with Irregular Pulse Monitor (Home) if…
Choose Verily Study Watch with Irregular Pulse Monitor (Home) if you require a prescription-only wearable device for unobtrusive, continuous physiological data collection from patients in a home setting. This is particularly suited for clinical research or remote patient monitoring programs focused on detecting irregular heart rhythms like atrial fibrillation and gathering comprehensive health data over extended periods.
View Study Watch with Irregular Pulse Monitor (Home) →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | EchoSolv AS | Study Watch with Irregular Pulse Monitor (Home) |
|---|---|---|
| Deployment | Cloud-based | Unknown |
| BAA Available | Yes AI-estimated | Unknown |
| FDA Status | Cleared AI-estimated | Unknown |
| HIPAA | Yes AI-estimated | Unknown |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
EchoSolv ASEchoSolv AS is designed to integrate seamlessly into existing clinical workflows by analyzing existing echocardiogram measurements and integrating with PACS, requiring no EMR integration. This minimizes disruption and offers ultra-fast risk detection. In contrast, the Study Watch is a wearable device that introduces a new patient-facing component, potentially requiring patient education and compliance, and a new data stream for clinicians to manage.
Clinical Value
EchoSolv ASEchoSolv AS provides direct, AI-powered clinical decision support for identifying patients at high risk for severe aortic stenosis, a critical and often underdiagnosed condition, directly impacting diagnostic pathways and intervention. While the Study Watch offers valuable irregular pulse monitoring for AFib detection and general physiological data collection, its primary use case appears broader (clinical research) and less focused on immediate, specific diagnostic decision support for a severe condition.
Pricing & Value
TieNeither EchoSolv AS nor the Study Watch provides publicly available pricing information, both requiring direct contact for details. Without transparent pricing, it is impossible to conduct a meaningful head-to-head comparison of their value propositions.
Enterprise Readiness
EchoSolv ASEchoSolv AS demonstrates strong enterprise readiness with clear FDA clearance, HIPAA compliance, and a BAA, coupled with its cloud-based deployment and integration with existing PACS workflows. The Study Watch, while FDA-cleared and offering a BAA, has a qualified HIPAA compliance statement due to reported past litigation, which could be a concern for enterprise adoption. Additionally, as a physical wearable device, it introduces logistical complexities for deployment and management within an enterprise setting.
Innovation
Study Watch with Irregular Pulse Monitor (Home)The Study Watch with Irregular Pulse Monitor showcases greater innovation through its advanced wearable technology, enabling unobtrusive, continuous collection of multi-modal physiological data, including ECG, heart rate, electrodermal activity, and inertial movements, along with environmental sensors. This represents a significant advancement in passive data acquisition for clinical research and remote monitoring. EchoSolv AS is innovative in its specific AI application for severe AS diagnosis using a measurement-based approach, but the Study Watch's foundational technology for data collection is arguably more groundbreaking.
Support & Docs
TieNeither the provided structured facts nor web searches yielded specific information regarding the availability, quality, or channels for customer support and documentation for either EchoSolv AS or the Study Watch. Therefore, it is not possible to distinguish between the two on this dimension.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | EchoSolv AS | Study Watch with Irregular Pulse Monitor (Home) |
|---|---|---|
| Name | EchoSolv AS | Study Watch with Irregular Pulse Monitor (Home) |
| Company | Echo IQ | Verily Life Sciences LLC |
| Tagline | Identify high-probability severe aortic stenosis (sAS) patients accurately, quickly, simply. | Making health data useful for healthier, more vibrant lives. |
| Key Features | AI-powered clinical decision support for severe aortic stenosis probability, Consistent severe AS probability and guideline check from measurements, Second reader support to help prioritize studies for closer review, Real-world readiness; AI does not use LVOT measurements, Faster clinical review using standardized, measurement-based AI and guideline analysis, Measurement-based AI (analyzes numerical measurements, not images), Designed to fit existing workflows (no EMR integration required, integrates with PACS), Ultra-fast risk detection (under 3 seconds) | On-demand single-channel ECG measurement, Irregular pulse monitoring for atrial fibrillation (AFib) detection, Multiple physiological sensors (heart rate, electrodermal activity, inertial movements), Environmental sensors, Long battery life (up to one week), Large internal data storage with compression, On-device data encryption for security, Cloud-based data processing with proprietary algorithms and machine learning |
Videos
Demos, reviews, and walkthroughs featuring EchoSolv AS and Study Watch with Irregular Pulse Monitor (Home).